Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corvus Pharmaceuticals (CRVS) Depreciation & Amortization (CF) (2022 - 2025)

Corvus Pharmaceuticals has reported Depreciation & Amortization (CF) over the past 4 years, most recently at $26000.0 for Q4 2025.

  • Quarterly results put Depreciation & Amortization (CF) at $26000.0 for Q4 2025, up 30.0% from a year ago — trailing twelve months through Dec 2025 was $105000.0 (up 23.53% YoY), and the annual figure for FY2025 was $105000.0, up 23.53%.
  • Depreciation & Amortization (CF) for Q4 2025 was $26000.0 at Corvus Pharmaceuticals, down from $28000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for CRVS hit a ceiling of $94000.0 in Q3 2022 and a floor of $20000.0 in Q4 2024.
  • Median Depreciation & Amortization (CF) over the past 4 years was $28500.0 (2023), compared with a mean of $44250.0.
  • Biggest five-year swings in Depreciation & Amortization (CF): crashed 70.21% in 2023 and later surged 38.1% in 2025.
  • Corvus Pharmaceuticals' Depreciation & Amortization (CF) stood at $94000.0 in 2022, then crashed by 70.21% to $28000.0 in 2023, then fell by 28.57% to $20000.0 in 2024, then grew by 30.0% to $26000.0 in 2025.
  • The last three reported values for Depreciation & Amortization (CF) were $26000.0 (Q4 2025), $28000.0 (Q3 2025), and $29000.0 (Q2 2025) per Business Quant data.